a total of 151 patients (age: 2474 years, mean: 55 +/- 10.3) diagnosed with peyronies disease were enrolled in a non-surgical treatment. In addition to medical histories and physical examinations, all patients underwent the following tests: penile ultrasound, IIEF questionnaire and photographic documentation. the penile curvature was measured by taking a photograph during maximum erection. all 151 patients were treated at different times and with different combinations of drugs, and afterwards, they were clinically studied and divided into five different treatment groups: 1st = verapamil (injection + iontophoresis) + vitamin E + topical diclofenac + blueberries; 2nd = verapamil (injection + iontophoresis) + vitamin E + topical diclofenac + propolis; 3rd = verapamil (injection) + vitamin E + topical Diclofenac; 4th = verapamil (iontophoresis) + vitamin E + topical diclofenac; 5th = verapamil (injection + iontophoresis) + topical diclofenac + blueberries + propolis. all patients were treated for 6 months after which they underwent the same follow-up tests as performed prior to the treatment. The following was achieved: group 1 had the most reduction in plaque size (-66.4%; p = 0.000), group 2 obtained the highest rate where penile curvature disappeared (24.5%; p = 0.019); the best results with reference to decrease in curvature angle were reached by the 2nd group (-14 degrees) and group 1 obtained -9.6 degrees (p = 0.000).

Paulis, G., D'Ascenzo, R., Nupieri, P., De Giorgio, G., Orsolini, G., Brancato, T., et al. (2012). Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: A study of 151 cases. INTERNATIONAL JOURNAL OF ANDROLOGY, 35(4), 521-527 [10.1111/j.1365-2605.2011.01219.x].

Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: A study of 151 cases

Brancato, T.;Alvaro, R.
2012-01-01

Abstract

a total of 151 patients (age: 2474 years, mean: 55 +/- 10.3) diagnosed with peyronies disease were enrolled in a non-surgical treatment. In addition to medical histories and physical examinations, all patients underwent the following tests: penile ultrasound, IIEF questionnaire and photographic documentation. the penile curvature was measured by taking a photograph during maximum erection. all 151 patients were treated at different times and with different combinations of drugs, and afterwards, they were clinically studied and divided into five different treatment groups: 1st = verapamil (injection + iontophoresis) + vitamin E + topical diclofenac + blueberries; 2nd = verapamil (injection + iontophoresis) + vitamin E + topical diclofenac + propolis; 3rd = verapamil (injection) + vitamin E + topical Diclofenac; 4th = verapamil (iontophoresis) + vitamin E + topical diclofenac; 5th = verapamil (injection + iontophoresis) + topical diclofenac + blueberries + propolis. all patients were treated for 6 months after which they underwent the same follow-up tests as performed prior to the treatment. The following was achieved: group 1 had the most reduction in plaque size (-66.4%; p = 0.000), group 2 obtained the highest rate where penile curvature disappeared (24.5%; p = 0.019); the best results with reference to decrease in curvature angle were reached by the 2nd group (-14 degrees) and group 1 obtained -9.6 degrees (p = 0.000).
2012
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/45
English
anthocyanides
iontophoresis
Peyronie's disease
propolis
verapamil
vitamin E
Paulis, G., D'Ascenzo, R., Nupieri, P., De Giorgio, G., Orsolini, G., Brancato, T., et al. (2012). Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: A study of 151 cases. INTERNATIONAL JOURNAL OF ANDROLOGY, 35(4), 521-527 [10.1111/j.1365-2605.2011.01219.x].
Paulis, G; D'Ascenzo, R; Nupieri, P; De Giorgio, G; Orsolini, G; Brancato, T; Alvaro, R
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/347451
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact